# doxorubicin hydrochloride

NDC: 46708-810
Generic name: doxorubicin hydrochloride
Labeler / Manufacturer: Alembic Pharmaceuticals Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SUSPENSION, LIPOSOMAL
Routes: INTRAVENOUS
Marketing started: 20250627

FDA application: ANDA219199

## Active ingredients

- DOXORUBICIN HYDROCHLORIDE: 2 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"46708-810"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=46708-810
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f8e001f5-441c-47cd-86f6-5d5e3de16bc0
